The following information and review could not have been accomplished without the creation and implementation of the Physician Payment Sunshine Act, a part of the 2010 Affordable Care Act. The investigation involving Pharma-doctor relationships started by an award-winning journalistic entity known as ProPublica, which initiated the investigation in 2010. Such reports disclosing Pharma companies' financial ties with doctors were because of legal settlements with the federal government.
Fresques (2019) published an investigative report that exposed a disturbing, but realistic conclusion: Doctors prescribe more of a medication if they receive money from a Pharma company tied to it (Tigas, Jones, Ornstein, & Groeger, 2019). The pattern is consistent for almost all the most widely prescribed brand-name medications in Medicare, including medications that treat diabetes, asthma, mental health, and more.
Dr. Asta has had significant financial ties with the medication manufacturer of Suboxone. The medication manufacturer of Suboxone goes by the official name Indivior Inc. Indivior Inc. was indicted by the Department of Justice for fraudulently marketing its opioid-containing product Suboxone.
Such marketing also includes prescriptions for buprenorphine-naloxone, which is correlated with increased prescription patterns from the doctors paid for by Indivior Inc., such as Dr. Asta. The conclusion is that Dr. Asta is increasing his prescriptions of opioid-comprised medications as opposed to treating the opioid-addiction disorders in his patients.
Thus, if you read the Department of Justice's federal criminal indictment of Indivior Inc., once you see this increased pattern of opioid-containing medications being prescribed by Dr. Asta, the malignant relationship between him and Indivior Inc. becomes incredulously apparent. Furthermore, Dr. Asta's treatment decisions are questionably dangerous.
According to publicly released reports on medicare.gov, Asta prescribed a whopping net worth of Suboxone-comprised medications (either Suboxone directly, or in the form of buprenorphine-naloxone) to his Medicare patients in 2020--totaling around $9,682.00 worth of opioid-related prescriptions. His documented prescription patterns of Suboxone and the similar buprenorphine-naloxone, corroborates the corruption revealed in the indictment of Indivior Inc. by the DOJ in 2019.
It is a random, but interesting observation, that Dr. Asta has told certain patients (such as me) that he does not prescribe Xanax due to its high probability of abuse compared to other benzodiazepines. However, Medicare released Asta's prescription records for 2020, and interestingly Xanax is in the top 10% of Asta's most frequently prescribed psychotropic medications for that year.
In other words, consider Dr. Asta unreliable.
My advice: avoidance and seek treatment elsewhere! read more